Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Mark Manfredi, PhD$62.3M
Market Cap • 24/04/20242016
(há 8 anos)
2021
(3 years ago)
NASDAQ
Listagem
Boston
Sede • Massachusetts80
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IKNASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.